S-18986
S-18986 is a synthetic compound that belongs to the class of amphiphilic benzylamine derivatives. It is known for its potential neuroprotective properties, which have been studied in various neurodegenerative diseases and conditions such as stroke, Alzheimer's disease, and Parkinson's disease.
Pharmacology[edit | edit source]
S-18986 is a positive allosteric modulator of the AMPA receptor, a type of ionotropic glutamate receptor that mediates fast synaptic transmission in the central nervous system. By enhancing the activity of these receptors, S-18986 can potentially improve cognitive function and protect neurons from damage.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the safety and efficacy of S-18986 in patients with neurodegenerative diseases. However, the results have been mixed, and further research is needed to determine the therapeutic potential of this compound.
Side Effects[edit | edit source]
Like all drugs, S-18986 can cause side effects. These may include nausea, vomiting, headache, and dizziness. Patients should be monitored closely for these and other potential side effects during treatment with S-18986.
See Also[edit | edit source]
S-18986 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD